RESULTS
75 CRSwNP patients participated in the study. 2 patients in rh-bFGF nasal-spray group and 1 patient in rh-bFGF nasal-drop group lost follow-up. 72 patients completed 1 year follow-up(FigureS1). The baseline information of the three groups matched well(Table 1).